Edgewise Therapeutics (EWTX) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Edgewise Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $199K and 6 sold $19.5M of EWTX stock on the open market.
Get emailed when insiders cluster-buy stocks like EWTX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
EWTX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $9.8M | 21 |
| Q2 2026 | — | 0 | $3.0M | 3 |
| Q1 2026 | — | 0 | $4.6M | 8 |
| Q4 2025 | $199K | 1 | $2.1M | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Edgewise Therapeutics, Inc. insider reported open-market purchases totaling $199K, while 6 insiders reported sales totaling $19.5M. 18 of 33 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 14SEC | Kevin KochCEO, President | Sell | 8,78261,677 held (−12%) | $43.64 | $383K | -10.5% | — |
| Aug 14SEC | Kevin KochCEO, President | Sell | 8,27653,401 held (−13%) | $43.66 | $361K | -10.5% | — |
| Aug 14SEC | Alan J RussellChief Scientific Officer | Sell | 3,23834,129 held (−9%) | $43.68 | $141K | -10.6% | — |
| Aug 14SEC | Joanne M. DonovanCmo | Sell Plan | 2,9198,625 held (−25%) | $43.41 | $127K | -10.0% | — |
| Aug 14SEC | Joanne M. DonovanCmo | Sell Plan | 2,83915,227 held (−16%) | $43.78 | $124K | -10.8% | — |
| Aug 14SEC | Joanne M. DonovanCmo | Sell Plan | 2,77912,448 held (−18%) | $43.71 | $121K | -10.6% | — |
| Aug 14SEC | Behrad DerakhshanChief Business Officer | Sell | 2,47531,826 held (−7%) | $43.70 | $108K | -10.6% | — |
| Aug 14SEC | John R MooreGeneral Counsel | Sell | 2,43920,274 held (−11%) | $43.81 | $107K | -10.8% | — |
| Aug 14SEC | John R MooreGeneral Counsel | Sell | 2,41917,697 held (−12%) | $43.80 | $106K | -10.8% | — |
| Aug 14SEC | Alan J RussellChief Scientific Officer | Sell | 2,27331,856 held (−7%) | $43.68 | $99K | -10.6% | — |
| Aug 14SEC | Behrad DerakhshanChief Business Officer | Sell | 2,17134,755 held (−6%) | $43.79 | $95K | -10.8% | — |
| Aug 14SEC | Kevin KochCEO, President | Sell | 91352,488 held (−2%) | $44.33 | $40K | -11.9% | — |
| Aug 14SEC | Joanne M. DonovanCmo | Sell Plan | 80011,544 held (−6%) | $44.52 | $36K | -12.3% | — |
| Aug 14SEC | Alan J RussellChief Scientific Officer | Sell | 39031,466 held (−1%) | $44.46 | $17K | -12.1% | — |
| Aug 14SEC | Behrad DerakhshanChief Business Officer | Sell | 30434,451 held (−1%) | $44.50 | $14K | -12.2% | — |
| Aug 14SEC | Behrad DerakhshanChief Business Officer | Sell | 15034,301 held (−0%) | $44.44 | $7K | -12.1% | — |
| Aug 14SEC | Joanne M. DonovanCmo | Sell Plan | 10412,344 held (−1%) | $44.43 | $5K | -12.1% | — |
| Aug 14SEC | John R MooreGeneral Counsel | Sell | 9920,116 held (−0%) | $44.50 | $4K | -12.2% | — |
| Aug 14SEC | John R MooreGeneral Counsel | Sell | 5920,215 held (−0%) | $44.41 | $3K | -12.0% | — |
| Jul 2SEC | Alan J RussellChief Scientific Officer | Sell Plan | 130,35294,203 held (−58%) | $39.41 | $5.1M | -0.9% | — |
| Jul 2SEC | Alan J RussellChief Scientific Officer | Sell Plan | 69,64824,555 held (−74%) | $39.41 | $2.7M | -0.9% | — |
| May 5SEC | Joanne M. DonovanCmo | Sell Plan | 50,0004,367 held (−92%) | $38.57 | $1.9M | +1.3% | — |
| May 5SEC | Joanne M. DonovanCmo | Sell Plan | 5,2304,367 held (−54%) | $31.29 | $164K | +24.8% | — |
| Apr 2SEC | Joanne M. DonovanCmo | Sell Plan | 28,6629,597 held (−75%) | $32.31 | $926K | +20.9% | — |
| Mar 31SEC | Joanne M. DonovanCmo | Sell Plan | 21,3389,597 held (−69%) | $32.12 | $685K | +21.6% | — |
| Mar 30SEC | Joanne M. DonovanCmo | Sell Plan | 9,62316,332 held (−37%) | $30.98 | $298K | +26.1% | — |
| Mar 30SEC | Joanne M. DonovanCmo | Sell Plan | 6,7359,597 held (−41%) | $30.98 | $209K | +26.1% | — |
| Jan 23SEC | Badreddin EdrisDirector | Sell Plan | 66,47719,820 held (−77%) | $29.44 | $2.0M | +32.7% | — |
| Jan 23SEC | Badreddin EdrisDirector | Sell Plan | 17,236104,365 held (−14%) | $29.44 | $507K | +32.7% | — |
| Jan 23SEC | Badreddin EdrisDirector | Sell Plan | 13,690121,601 held (−10%) | $29.44 | $403K | +32.7% | — |
| Jan 23SEC | Badreddin EdrisDirector | Sell Plan | 10,46386,297 held (−11%) | $29.44 | $308K | +32.7% | — |
| Jan 23SEC | Badreddin EdrisDirector | Sell Plan | 7,60596,760 held (−7%) | $29.44 | $224K | +32.7% | — |
| Nov 13SEC | Alan J RussellChief Scientific Officer | Sell | 100,00023,400 held (−81%) | $21.12 | $2.1M | +84.9% | — |
| Nov 13SEC | Jonathan C FoxDirector | Buy | 10,70023,702 held (+82%) | $18.64 | $199K | +109.5% | — |
Insiders at Edgewise Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Alan J RussellChief Scientific Officer | — | $10.3M | Aug 14, 2026 | — |
| Joanne M. DonovanCmo | — | $4.6M | Aug 14, 2026 | — |
| Badreddin EdrisDirector | — | $3.4M | Jan 23, 2026 | — |
| Kevin KochCEO, President | — | $785K | Aug 14, 2026 | — |
| Jonathan C FoxDirector | $199K | — | Nov 13, 2025 | — |
| Behrad DerakhshanChief Business Officer | — | $223K | Aug 14, 2026 | — |
| John R MooreGeneral Counsel | — | $220K | Aug 14, 2026 | — |
EWTX stock: common questions
Are Edgewise Therapeutics, Inc. insiders buying EWTX stock?
In the past 12 months, 1 insiders reported open-market purchases of EWTX worth $199K. The latest was Director Jonathan C Fox bought $199K of EWTX at $18.64 — first open-market purchase in our records; raises the stake by 82%.
Are Edgewise Therapeutics, Inc. insiders selling EWTX stock?
6 insiders reported sales worth $19.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is EWTX's 52-week range?
Over the past year EWTX has traded between $14.70 and $48.35. It last closed at $39.06 on Oct 9, 2026.